These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10337862)

  • 1. Differences in the cellular processing of AspB10 human insulin compared with human insulin and LysB28ProB29 human insulin.
    Hamel FG; Siford GL; Fawcett J; Chance RE; Frank BH; Duckworth WC
    Metabolism; 1999 May; 48(5):611-7. PubMed ID: 10337862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assembly and dissociation of human insulin and LysB28ProB29-insulin hexamers: a comparison study.
    Birnbaum DT; Kilcomons MA; DeFelippis MR; Beals JM
    Pharm Res; 1997 Jan; 14(1):25-36. PubMed ID: 9034217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin and analogue effects on protein degradation in different cell types. Dissociation between binding and activity.
    Fawcett J; Hamel FG; Bennett RG; Vajo Z; Duckworth WC
    J Biol Chem; 2001 Apr; 276(15):11552-8. PubMed ID: 11116143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin inhibition of the proteasome is dependent on degradation of insulin by insulin-degrading enzyme.
    Bennett RG; Fawcett J; Kruer MC; Duckworth WC; Hamel FG
    J Endocrinol; 2003 Jun; 177(3):399-405. PubMed ID: 12773120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The long acting human insulin analog HOE 901: characteristics of insulin signalling in comparison to Asp(B10) and regular insulin.
    Berti L; Kellerer M; Bossenmaier B; Seffer E; Seipke G; Häring HU
    Horm Metab Res; 1998 Mar; 30(3):123-9. PubMed ID: 9566852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [125I]-insulin metabolism by the rat liver in vivo: evidence that a neutral thiol-protease mediates rapid intracellular insulin degradation.
    Williams FG; Johnson DE; Bauer GE
    Metabolism; 1990 Mar; 39(3):231-41. PubMed ID: 2407925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physicochemical basis for the rapid time-action of LysB28ProB29-insulin: dissociation of a protein-ligand complex.
    Bakaysa DL; Radziuk J; Havel HA; Brader ML; Li S; Dodd SW; Beals JM; Pekar AH; Brems DN
    Protein Sci; 1996 Dec; 5(12):2521-31. PubMed ID: 8976561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of insulin domains important for binding to and degradation by endosomal acidic insulinase.
    Authier F; Danielsen GM; Kouach M; Briand G; Chauvet G
    Endocrinology; 2001 Jan; 142(1):276-89. PubMed ID: 11145591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin glulisine--a comprehensive preclinical evaluation.
    Stammberger I; Seipke G; Bartels T
    Int J Toxicol; 2006; 25(1):25-33. PubMed ID: 16510354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of high affinity insulin analogues to assess the functional relationships between insulin receptor trafficking, mitogenic signaling and mRNA expression in rat liver.
    Authier F; Merlen C; Amessou M; Danielsen GM
    Biochimie; 2004 Mar; 86(3):157-66. PubMed ID: 15134829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and characterization of a cocrystalline suspension of [LysB28,ProB29]-human insulin analogue.
    DeFelippis MR; Bakaysa DL; Bell MA; Heady MA; Li S; Pye S; Youngman KM; Radziuk J; Frank BH
    J Pharm Sci; 1998 Feb; 87(2):170-6. PubMed ID: 9519149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How to determine the size of folding nuclei of protofibrils from the concentration dependence of the rate and lag-time of aggregation. II. Experimental application for insulin and LysPro insulin: aggregation morphology, kinetics, and sizes of nuclei.
    Selivanova OM; Suvorina MY; Dovidchenko NV; Eliseeva IA; Surin AK; Finkelstein AV; Schmatchenko VV; Galzitskaya OV
    J Phys Chem B; 2014 Feb; 118(5):1198-206. PubMed ID: 24428561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel insulin analog with unique properties: LysB3,GluB29 insulin induces prominent activation of insulin receptor substrate 2, but marginal phosphorylation of insulin receptor substrate 1.
    Rakatzi I; Ramrath S; Ledwig D; Dransfeld O; Bartels T; Seipke G; Eckel J
    Diabetes; 2003 Sep; 52(9):2227-38. PubMed ID: 12941761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lys(B28), Pro(B29)]-human insulin. A rapidly absorbed analogue of human insulin.
    Howey DC; Bowsher RR; Brunelle RL; Woodworth JR
    Diabetes; 1994 Mar; 43(3):396-402. PubMed ID: 8314011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The trafficking and processing of insulin and insulin receptors in cultured rat hepatocytes.
    Levy JR; Olefsky JM
    Endocrinology; 1987 Dec; 121(6):2075-86. PubMed ID: 3315635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of new insulin analogues HMR1964 (insulin glulisine) and HMR1423 on insulin receptors.
    Hennige AM; Strack V; Metzinger E; Seipke G; Häring HU; Kellerer M
    Diabetologia; 2005 Sep; 48(9):1891-7. PubMed ID: 16052329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of 125-I-insulin binding and degradation to isolated rat hepatocytes and liver membranes.
    Olefsky J; Johnson J; Liu F; Edwards P; Baur S
    Diabetes; 1975 Sep; 24(9):801-10. PubMed ID: 169175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the insulin analogue [LYS(B28),PRO(B29)] on blood glucose control.
    Trautmann ME
    Horm Metab Res; 1994 Dec; 26(12):588-90. PubMed ID: 7705764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth promoting and metabolic activity of the human insulin analogue [GlyA21,ArgB31,ArgB32]insulin (HOE 901) in muscle cells.
    Bähr M; Kolter T; Seipke G; Eckel J
    Eur J Pharmacol; 1997 Feb; 320(2-3):259-65. PubMed ID: 9059862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin receptors in isolated human adipocytes. Characterization by photoaffinity labeling and evidence for internalization and cellular processing.
    Berhanu P; Kolterman OG; Baron A; Tsai P; Olefsky JM; Brandenburg D
    J Clin Invest; 1983 Dec; 72(6):1958-70. PubMed ID: 6358259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.